Eric K. H. Chan

发表

Development of a novel patient-reported outcome measure to assess signs and symptoms of COVID-19

J. Sadoff, S. Fehnel, A. Slagle, 2022, Journal of Patient-Reported Outcomes.

Development of patient- and observer-reported outcome measures to assess COVID-19 signs and symptoms in children and adolescents

S. Fehnel, C. Romano, J. Ruiz-Guiñazú, 2023, Journal of Patient-Reported Outcomes.

Impact of Stigma on People Living with Chronic Hepatitis B

J. Smith-Palmer, W. Valentine, K. Bonroy, 2020, Patient related outcome measures.

Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS study

A. Chanan-Khan, A. Howes, N. Sengupta, 2018, Leukemia & lymphoma.

The effect of intravenous golimumab on health-related quality of life and work productivity in adult patients with active ankylosing spondylitis: results of the phase 3 GO-ALIVE trial

J. Reveille, A. Deodhar, K. Lo, 2020, Clinical Rheumatology.

PROM_A_226936 95..107

J. Smith-Palmer, W. Valentine, K. Bonroy, 2020 .

The effect of intravenous golimumab on health-related quality of life and work productivity in patients with active psoriatic arthritis: results of the Phase 3 GO-VIBRANT trial

A. Ogdie, J. Walsh, A. Kavanaugh, 2021, Clinical Rheumatology.

Psychometric evaluation of the Symptoms of Infection with Coronavirus-19 (SIC): results from a cross-sectional study and a phase 3 clinical trial

Y. Liu, J. Sadoff, S. Fehnel, 2023, Journal of Patient-Reported Outcomes.

Comparative assessment of reported symptoms of influenza, respiratory syncytial virus, and human metapneumovirus infection during hospitalization and post‐discharge assessed by Respiratory Intensity and Impact Questionnaire

E. Walsh, A. Falsey, R. Osborne, 2021, Influenza and other respiratory viruses.

Efficacy and Safety of an Ad26.RSV.preF-RSV preF Protein Vaccine in Older Adults.

A. Falsey, J. Sadoff, J. Menten, 2023, The New England journal of medicine.

Psychometric Validation of the Hepatitis C Symptom and Impact Questionnaire (HCV-SIQv4) in a Diverse Sample of Adults with Chronic Hepatitis C Virus Infection Treated with an Interferon-free Simeprevir-containing Regimen

T. Willgoss, H. Kitchen, A. Trigg, 2019, Journal of health economics and outcomes research.

Effects of Intravenous Golimumab on Health-Related Quality of Life in Patients with Ankylosing Spondylitis: 28-Week Results of the GO-ALIVE Trial.

J. Reveille, A. Deodhar, Chenglong Han, 2020, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Evaluation of symptoms in respiratory syncytial virus infection in adults: psychometric evaluation of the Respiratory Infection Intensity and Impact Questionnaire™ symptom scores

L. Nelson, R. Osborne, G. Ispas, 2023, Journal of Patient-Reported Outcomes.

Clinical Outcomes and Quantitative HBV Surface Antigen Levels in Diverse Chronic Hepatitis B Patients in Canada: A Retrospective Real-World Study of CHB in Canada (REVEAL-CANADA)

C. Coffin, S. Haylock-Jacobs, C. Osiowy, 2022, Viruses.

Effects of Intravenous Golimumab on Health-Related Quality of Life in Patients With Psoriatic Arthritis: 24-Week Results of the GO-VIBRANT Trial.

A. Kavanaugh, Chenglong Han, Nan Li, 2020, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study

J. Reveille, A. Deodhar, K. Lo, 2023, Rheumatology and Therapy.